Streetbeat News

Analyst Ratings

ALL

In the last three months, 13 analysts have provided diverse ratings for Allstate (NYSE:ALL), with a trend towards bullish sentiment. The average 12-month price target is $159.69, up 15.57% from the previous $138.18. Analysts from firms like BMO Capital, UBS, TD Cowen, Goldman Sachs, Jefferies, Morgan Stanley, HSBC, Raymond James, Piper Sandler, and Roth MKM have raised their price targets, reflecting optimism about Allstate's future performance. Despite this, Allstate's financial indicators such as revenue growth, net margin, ROE, ROA, and debt management show mixed results, with some metrics below industry averages.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 2:00 pm

SNV

Keefe, Bruyette & Woods analyst Brady Gailey has maintained an Outperform rating on Synovus Financial Corp. (NYSE:SNV) and increased the price target from $45 to $46.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 2:00 pm

NTRS

RBC Capital analyst Gerard Cassidy has maintained an Outperform rating on Northern Trust (NASDAQ:NTRS) and increased the price target from $82 to $86.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:58 pm

KEY

Keefe, Bruyette & Woods analyst David Konrad has maintained an Outperform rating on KeyCorp (NYSE:KEY) but lowered the price target from $17 to $16, as reported on January 18, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:58 pm

ABBV

ADSK

PFE

XLV

On CNBC's 'Halftime Report Final Trades,' Liz Young, Joshua Brown, Karen Firestone, and Bill Baruch made their stock picks. Young chose Health Care Select Sector SPDR Fund (XLV), noting its recent slight slip. Brown selected Pfizer (PFE), mentioning its December bottom and CEO's commitment to the obesity market despite a drug setback. Firestone picked Autodesk (ADSK), citing a Keybanc analyst's overweight rating and raised price target. Baruch chose AbbVie (ABBV), highlighting an exclusive agreement with Enigma Biomedical and upcoming financial results, with analysts expecting earnings of $2.9 per share on $13.99 billion revenue.

Portfolio Pulse from Avi Kapoor

January 19, 2024 | 1:57 pm

MTB

RBC Capital analyst Gerard Cassidy has reiterated an Outperform rating on M&T Bank (NYSE:MTB) and maintained a price target of $160.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:55 pm

CBSH

Keefe, Bruyette & Woods analyst Christopher McGratty has maintained a 'Market Perform' rating on Commerce Bancshares (NASDAQ:CBSH) and increased the price target from $54 to $56.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:50 pm

KEY

RBC Capital analyst Gerard Cassidy has maintained an Outperform rating on KeyCorp (NYSE:KEY) and increased the price target from $13 to $15.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:49 pm

COUR

Coursera's stock (COUR) is trading lower following a downgrade by Goldman Sachs from Neutral to Sell, with a reduced price target from $18 to $14.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:49 pm

CBSH

Keefe, Bruyette & Woods analyst Christopher McGratty has maintained a 'Market Perform' rating on Commerce Bancshares (NASDAQ:CBSH) and increased the price target from $54 to $56.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:49 pm